Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Acurx Pharmaceuticals, Inc. ACXP

Full chart Compare
Set alert

Price alert · ACXP

All alert types
1.04 USD +0.02 (+1.96%)

Nov 4, 2026, 10:32 AM EST

1.03 Day range 1.08
1.01 52-week range 7.54
YTD
-58.23%
1 year
-78.42%

Analyst view

Consensus: buy

Buy
Price target (mean) 11.19 +976.0% upside
Target (low)
10.00
Target (mean)
11.19
Target (high)
12.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy0
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 2
  • 1 month ago 2
  • 2 months ago 2

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ACXP analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.18-0.18 – -0.18-0.38+52.6%00.0%1
Next quarter-0.38-0.38 – -0.38-0.28-35.7%00.0%1
Current year-0.89-0.89 – -0.89-1.15+22.6%00.0%1
Next year-2.06-2.06 – -2.06-0.89-131.5%00.0%1

Upgrades and downgrades

The latest rating changes

ACXP analyst upgrades and downgrades
DateFirmActionFromTo
Dec 10, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 12, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 16, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 19, 2024HC Wainwright & Co.MaintainedBuyBuy
Feb 28, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 15, 2023HC Wainwright & Co.MaintainedBuyBuy
Nov 15, 2023HC Wainwright & Co.ReiteratedBuyBuy
Sep 13, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 15, 2023HC Wainwright & Co.MaintainedBuyBuy
May 15, 2023HC Wainwright & Co.ReiteratedBuyBuy
Apr 11, 2023HC Wainwright & Co.Reiterated—Buy
Mar 17, 2023HC Wainwright & Co.Reiterated—Buy
Dec 19, 2022HC Wainwright & Co.Initiated—Buy
Oct 20, 2022Alliance Global PartnersInitiated—Buy
Nov 29, 2021Maxim GroupInitiated—Buy